Arrington Capital Management LLC Makes New $4.56 Million Investment in Hyperliquid Strategies Inc $PURR

Arrington Capital Management LLC acquired a new stake in Hyperliquid Strategies Inc (NASDAQ:PURR) in the fourth quarter, HoldingsChannel reports. The firm acquired 1,280,001 shares of the company’s stock, valued at approximately $4,557,000. Hyperliquid Strategies makes up about 4.3% of Arrington Capital Management LLC’s portfolio, making the stock its 4th largest holding.

Other institutional investors have also modified their holdings of the company. Paradigm Operations LP acquired a new position in shares of Hyperliquid Strategies in the fourth quarter valued at approximately $20,327,000. Militia Capital Partners LP acquired a new position in shares of Hyperliquid Strategies in the fourth quarter valued at approximately $1,784,000. 683 Capital Management LLC acquired a new position in shares of Hyperliquid Strategies in the fourth quarter valued at approximately $5,660,000. OMERS ADMINISTRATION Corp acquired a new position in shares of Hyperliquid Strategies in the fourth quarter valued at approximately $156,000. Finally, Pantera Capital Partners LP acquired a new position in shares of Hyperliquid Strategies in the fourth quarter valued at approximately $14,545,000. Institutional investors and hedge funds own 9.45% of the company’s stock.

Hyperliquid Strategies Stock Down 2.3%

Shares of PURR stock opened at $9.81 on Thursday. Hyperliquid Strategies Inc has a one year low of $3.01 and a one year high of $11.62. The stock’s 50 day moving average is $7.42. The firm has a market capitalization of $1.42 billion, a price-to-earnings ratio of -1.33 and a beta of 1.64.

Hyperliquid Strategies (NASDAQ:PURR) last issued its quarterly earnings results on Thursday, May 7th. The company reported $1.01 EPS for the quarter. The company had revenue of $2.63 million for the quarter. Sell-side analysts anticipate that Hyperliquid Strategies Inc will post 2.1 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Weiss Ratings raised shares of Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, June 3rd. Maxim Group assumed coverage on shares of Hyperliquid Strategies in a research report on Friday, April 24th. They issued a “buy” rating and a $10.00 price objective for the company. Wall Street Zen raised shares of Hyperliquid Strategies to a “hold” rating in a research report on Saturday, February 21st. Chardan Capital reissued a “buy” rating and issued a $9.75 price objective on shares of Hyperliquid Strategies in a research report on Friday, June 12th. Finally, Cantor Fitzgerald upped their price target on shares of Hyperliquid Strategies from $6.00 to $8.00 and gave the stock an “overweight” rating in a research report on Monday, May 11th. Three analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Hyperliquid Strategies presently has a consensus rating of “Moderate Buy” and a consensus target price of $9.25.

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.